Stabilization of Factor VIII in Plasma by the von Willebrand Factor
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
In normal plasma, the ratio of the procoagulant activity of factor VIII (VIII(AHF)) to that of the von Willebrand factor activity (ristocetin cofactor, VIII(VWF)) or factor VIII antigen (VIII(AGN)) is approximately 1, but ratios > 1 (e.g., VIII(AHF) > VIII(VWF) or VIII(AGN)) may be observed in some patients with von Willebrand's disease and in the "late" posttransfusion plasmas of patients with this disorder. The lability of VIII(AHF) was studied by incubating plasma, diluted 1:10 in imidazole buffer pH 7.1, for 6 h at 37 degrees C. With normal plasmas, 77+/-12% (SD) of the original VIII(AHF) activity remained after incubation. VIII(AHF) was labile (e.g., 35-55% residual activity) in the "late" posttransfusion plasmas (VIII(AHF) >> VIII(VWF)) of a patient with von Willebrand's disease, but not in the "early" posttransfusion plasmas (VIII(AHF) approximately VIII(VWF)). VIII(AHF) was also labile in the (base-line) plasmas of three patients with von Willebrand's disease in whom the ratios of VIII(AHF) to VIII(VWF) were 4.4 to 8.1, but not in the plasmas of four other patients in whom the ratio was approximately 1. The electrophoretic mobility of factor VIII antigen was increased in two of the three patients with labile VIII(AHF). In both of these patients, and in the late posttransfusion plasmas, labile VIII(AHF) activity could be stabilized by the addition of purified von Willebrand factor (lacking VIII(AHF) activity) or by hemophilic plasma, but not by plasmas of patients with severe von Willebrand's disease. Thus, VIII(VWF) may serve to stabilize VIII(AHF) and this might explain the posttransfusion findings in von Willebrand's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 20,298
Platelet Physiology and Abnormalities of Platelet Function: (First of Two Parts)
Weiss, H. J. (1975) · New England Journal of Medicine · doi:10.1056/nejm197509112931105 · Cited by 445
Self-citationIsolation and Characterization of Human Factor VIII (Antihemophilic Factor)
Legaz, M. E., Schmer, G., Counts, R. B., & Davie, E. W. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43824-6 · Cited by 214
The effects of epinephrine infusion in patients with von Willebrand's disease.
Rickles, F. R., Hoyer, L. W., Rick, M. E., & Ahr, D. J. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108432 · Cited by 66
Self-citation
Cited by
Koster, T., Vandenbroucke, J. P., Rosendaal, F. R., Briët, E., Rosendaal, F. R., & Blann, A. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90166-3 · Cited by 1,131
Cell Biology of von Willebrand Factor
Wagner, D. D. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.001245 · Cited by 597
A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis
Denis, C., Methia, N., Frenette, P. S., Rayburn, H., Ullman-Culleré, M., Hynes, R. O., & Wagner, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9524 · Cited by 513
Treatment of von Willebrand's Disease
Mannucci, P. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040403 · Cited by 484
The Life Cycle of Coagulation Factor VIII in View of Its Structure and Function
Lenting, P. J., van Mourik, J. A., & Mertens, K. (1998) · Blood · doi:10.1182/blood.v92.11.3983 · Cited by 451
Metadata
- Authors
- Weiss, H. J., Sussman, I. I., & Hoyer, L. W.
- Venue
- Journal of Clinical Investigation
- Published
- 1977-08-01
- Volume
- 60
- Issue
- 2
- Pages
- 390-404
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2108868109
- Cited by
- 409
- References
- 4
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.